These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4979433)

  • 21. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 22. [True Mycobacterium tuberculosis drug resistance].
    Terentieva AS
    Probl Tuberk; 1981 Mar; (3):67-9. PubMed ID: 6785746
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inoculability and drug resistance of Mycobacterium tuberculosis in patients with peripheral tuberculous lymphadenitis].
    Maskeev KM; Sidorkina EV; Krivtsova AE; Kim D; Eretina NG
    Probl Tuberk; 1971; 49(8):81-5. PubMed ID: 5005005
    [No Abstract]   [Full Text] [Related]  

  • 24. [The change in drug resistance of resistant Mycobacterium tuberculosis H37Rv strains after successive transfers on Ogawa medium for seven years].
    Yamadori H; Shibata A; Inagake H
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):20-5. PubMed ID: 6442171
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biological features and problems in detection of extrapulmonary tuberculosis pathogen].
    Vishnevskiĭ BI; Manicheva OA; Vishnevskaia EB; Otten TF
    Probl Tuberk; 1998; (2):34-6. PubMed ID: 9613184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specificity of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
    Pavlov EP
    Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5004351
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. III. Cross resistance of R.P].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):38-42. PubMed ID: 6442174
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics of antituberculous action in vitro of pyrazine-2-carboxylic acid derivatives].
    Pavlov EP
    Probl Tuberk; 1971; 49(7):76-9. PubMed ID: 5005811
    [No Abstract]   [Full Text] [Related]  

  • 31. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter III. The development of drug resistance (author's transl)].
    Yamadori H
    Kekkaku; 1981 Nov; 56(11):521-4. PubMed ID: 6799686
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the 1314TH resistant media].
    Hayashi N; Inada S; Kobayashi H; Hara M; Yamagiwa N
    Iryo; 1969 Feb; 23(2):179-82. PubMed ID: 4979517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 34. [The monitoring of the drug resistance of the causative agent of tuberculosis in Russia in 1979-1998].
    Dorozhkova IR; Popov SA; Medvedeva IM
    Probl Tuberk; 2000; (5):19-22. PubMed ID: 11077846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of native and lyophilized Loewenstein-Jensen's solid media in determining drug resistance on mycobacterium tuberculosis strains].
    Korneev AA; Golyshevskaia VI; Sevast'ianova EV; Safonova SG; Puzanov VA; Maslennikova IuV; Katulina NI; Stoiunin MB
    Probl Tuberk; 1999; (4):25-7. PubMed ID: 10479928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of resistance to antituberculous drugs in Spain.
    Casal M
    Rev Latinoam Microbiol; 1980; 22(4):161-2. PubMed ID: 6794121
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of chloramphenicol against drug resistant strains of Mycobacterium tuberculosis.
    Narayanan RA
    Hindustan Antibiot Bull; 1984; 26(3-4):102-4. PubMed ID: 6442714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antimicrobial drug therapy and microbial sensitivity tests-- antitubercular agents and microbial sensitivity tests].
    Abe C
    Rinsho Byori; 1997 Jul; Suppl 105():191-5. PubMed ID: 9379539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.